☆ 4.6 Letter

Dynamic susceptibility contrast MRI measures of relative cerebral blood volume continue to show promise as an early response marker in the setting of bevacizumab treatment

NEURO-ONCOLOGY (2015)

Journal

NEURO-ONCOLOGY

Volume 17, Issue 11, Pages 1538-1539

Publisher

OXFORD UNIV PRESS INC

DOI: 10.1093/neuonc/nov163

Keywords

Funding

NCI NIH HHS [R01 CA082500, U01 CA176110] Funding Source: Medline

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Dynamic susceptibility contrast MRI measures of relative cerebral blood volume continue to show promise as an early response marker in the setting of bevacizumab treatment

Journal

NEURO-ONCOLOGY

Publisher

OXFORD UNIV PRESS INC

Keywords

Categories

Funding

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Dynamic susceptibility contrast MRI measures of relative cerebral blood volume continue to show promise as an early response marker in the setting of bevacizumab treatment

Journal

NEURO-ONCOLOGY

Publisher

OXFORD UNIV PRESS INC

Keywords

Categories

Funding

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper